New York, New York, United States Prospect Capital Management L.P. is the famous VC, which was founded in 1988. The leading representative office of defined VC is situated in the New York. The venture was found in North America in United States.
The high activity for fund was in 2000. Opposing the other organizations, this Prospect Capital Management L.P. works on 15 percentage points more the average amount of lead investments. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top amount of exits for fund were in 2016.
The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Biotechnology, Medical Device. Among the various public portfolio startups of the fund, we may underline Comet Systems, InfoRocket.com, Biospect
We also calculated 15 valuable employees in our database.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Prospect Capital Management L.P., startups are often financed by Prospect Venture Partners, Three Arch Partners, Sutter Hill Ventures. The meaningful sponsors for the fund in investment in the same round are Intel Capital, Versant Ventures, Venrock. In the next rounds fund is usually obtained by Prospect Venture Partners, Three Arch Partners, New Leaf Venture Partners.
Related Funds
| Fund Name | Location |
| Aereco | - |
| AJS | Japan, Yamanashi, Yamanashi Prefecture |
| Baohui Equity Investment | China, Fujian, Xiamen |
| Beijing Zhangshang Tong Wangluo Jishu Co., Ltd. | Beijing, Beijing, China |
| Charoen Pokphand Group | Bangkok, Krung Thep, Thailand |
| Claritas Capital | Nashville, Tennessee, United States |
| Elsted Capital Partners | New York, New York, United States |
| Emkan Capital | Ar Riyad, Riyadh, Saudi Arabia |
| Epidarex Capital | Bethesda, Maryland, United States |
| FM Global | Connecticut, Hartford, United States |
| Huarong International Financial Holdings | Beijing, Beijing, China |
| REach | Chicago, Illinois, United States |
| Rich Products Ventures | Buffalo, New York, United States |
| Rockaway Capital | Czech Republic, Prague, Prague |
| Silver Chalice Ventures | Chicago, Illinois, United States |
| The Kraft Group | Boxborough, Massachusetts, United States |
| Z Corporation | Burlington, Massachusetts, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Portola Pharmaceuticals | $70M | 07 May 2007 | South San Francisco, California, United States | ||
Biospect | $27M | 21 Oct 2003 | South San Francisco, California, United States | ||
| $20M | 11 Jul 2000 | New York, United States | |||
InfoRocket.com | $25M | 09 May 2000 | New York, New York, United States | ||
Sportvision | $9M | 14 Jul 1999 | Durham, North Carolina, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Portola Pharmaceuticals | $70M | 07 May 2007 | South San Francisco, California, United States | ||
Biospect | $27M | 21 Oct 2003 | South San Francisco, California, United States | ||
| $20M | 11 Jul 2000 | New York, United States | |||
InfoRocket.com | $25M | 09 May 2000 | New York, New York, United States | ||
Sportvision | $9M | 14 Jul 1999 | Durham, North Carolina, United States |
